| Log in
Photo Credit: Thinkstock

Exclusive: India Life Sciences Fund II put Rs 246 cr in 3 firms last quarter

03 April, 2017

Healthcare-focussed private equity fund India Life Sciences Fund II, which is advised by InvAscent India, invested Rs 246 crore (around $38 million) across three companies last qua ....

To read the Full Story

Definitive news, exclusives, analyses and videos

  • Exclusive reporting, expert analysis and commentary on PE/VC/M&A deals & dealmakers
  • Daily, weekly and monthly curated newsletters on the deal ecosystem in India
  • Breaking news alerts
  • Participation in marquee events at concessional rates

Comprehensive | Accurate | Unbiased | Impeccably sourced


Leave Your Comment
How was Zephyr Peacock's exit from Aizant Drug?

How was Zephyr Peacock’s exit from Aizant Drug?

Bruhadeeswaran R 8 months ago
Zephyr Peacock India, a mid-market private equity (PE) fund that invests in-...
Exclusive: India Life Sciences Fund II makes new pharma bet

Exclusive: India Life Sciences Fund II makes new pharma bet

Joseph Rai 6 months ago
Healthcare-focussed private equity fund India Life Sciences Fund II, which is...
Exclusive: Tata Capital Healthcare Fund makes second pharma bet of 2017

Exclusive: Tata Capital Healthcare Fund makes second pharma bet of 2017

Joseph Rai 7 months ago
Tata Capital Healthcare Fund, the healthcare-focussed private equity arm of...
No Comments

Exclusive: India Life Sciences Fund II put Rs 246 cr in 3 firms last quarter

Powered by WordPress.com VIP